UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Of mice and men: lost in translation

Annals of oncology, 2019-04, Vol.30 (4), p.499-500

2019

Volltextzugriff (PDF)

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

ESMO open, 2022-02, Vol.7 (1), p.100336-100336, Article 100336

2022

Volltextzugriff (PDF)

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e86-e86

2024

Volltextzugriff (PDF)

EPH186 Real-World Biomarker Prevalence and Treatment Patterns Among Metastatic Colorectal Cancer Patients Who Underwent NGS Testing

Value in health, 2024-06, Vol.27 (6), p.S186-S186

2024

Volltextzugriff (PDF)

Of mice and men: lost in translation

Annals of oncology, 2019-04, Vol.30 (4), p.499

2019

Volltextzugriff (PDF)

A-456 - A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma

EJC skin cancer, 2024, Vol.2

2024

Volltextzugriff (PDF)

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma

EJC skin cancer, 2024, Vol.2, p.100214, Article 100214

2024

Volltextzugriff (PDF)

Development of lentiviral vectors for gene therapy for Usher syndrome type 1B

Acta ophthalmologica Scandinavica, 2007-09, Vol.85 (s240), p.0-0

2007

Volltextzugriff (PDF)

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope

Current oncology reports, 2017-12, Vol.19 (12), p.78-8, Article 78

2017

Volltextzugriff (PDF)

Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

Gynecologic oncology, 2024-07, Vol.186, p.182-190

2024

Volltextzugriff (PDF)

Tucatinib and trastuzumab for previously treated HER2-positive metastatic biliary tract cancer (SGNTUC-019): A phase 2 basket study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4007-4007

2023

Volltextzugriff (PDF)

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9515-9515

2021

Volltextzugriff (PDF)

Outcomes of patients with gene fusion driven cancers treated on early phase clinical trials

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2590-2590

2018

Volltextzugriff (PDF)

Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF -Mutated Malignancies

JCO precision oncology, 2018 (2), p.1-12

2018

Volltextzugriff (PDF)

Hormonal interrelationships in symptomatic epilepsy

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1994, Vol.94 (4), p.6

1994

Volltextzugriff (PDF)

Structure and ultraviolet absorption spectra of indazolones

Chemistry of heterocyclic compounds (New York, N.Y. 1965), 1967, Vol.2 (1), p.68-71

1967

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Of mice and men: lost in translation

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)

EPH186 Real-World Biomarker Prevalence and Treatment Patterns Among Metastatic Colorectal Cancer Patients Who Underwent NGS Testing

Of mice and men: lost in translation

A-456 - A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma

Development of lentiviral vectors for gene therapy for Usher syndrome type 1B

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope

Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

Tucatinib and trastuzumab for previously treated HER2-positive metastatic biliary tract cancer (SGNTUC-019): A phase 2 basket study

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma

Outcomes of patients with gene fusion driven cancers treated on early phase clinical trials

Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF -Mutated Malignancies

Hormonal interrelationships in symptomatic epilepsy

Structure and ultraviolet absorption spectra of indazolones

Suchergebnisse filtern